Describes international variations in preemptive arteriovenous fistula creation and assesses patient outcomes, suggesting areas for improvement.
Current knowledge about how preemptive arteriovenous (AV) fistula creation has been implemented is mostly based on information obtained retrospectively from patients who have initiated hemodialysis (HD). There is also a lack of evidence on patient outcomes following AV access creation, especially HD competing risks (e.g., death prior to HD initiation). Our study’s aims were to describe international variations in practice patterns of preemptive AV fistula creation, and to assess patient outcomes following this creation.
No takes yet. Share an insight, caveat, or question.
Tabcheh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: